SCHEMBL21137837

SCHEMBL21137837

CCOC(=O)c1coc(-c2cnc(SC)nc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 4/20 0.43
TDP1 Q9NUW8 2/20 0.43
POLB P06746 1/20 0.43
SYK P43405 2/20 0.41
MAPT P10636 5/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
HPGD P15428 2/20 0.40
CYP1A2 P05177 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.39
FOS P01100 1/20 0.39
JUN P05412 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
NLRP3 Q96P20 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22551275 0.81 MEN1 (0.42) MEN1KMT2AALDH1A1KDM4E
SCHEMBL22618744 0.80 PTPN1 (0.31) MEN1KMT2AALDH1A1TDP1POLB
SCHEMBL16896553 0.79 CYP1A2 (0.42) CYP1A2NLRP3GABRA2GABRB2
SCHEMBL23193188 0.79 PTPN1 (0.32)
SCHEMBL14820135 0.78 CYP1A2 (0.49) MEN1KMT2AALDH1A1TDP1POLB
SCHEMBL16898794 0.77 CYP1A2 (0.45) MEN1KMT2AALDH1A1POLBMAPT
SCHEMBL2792417 0.77 ALDH1A1 (0.59) KMT2AALDH1A1MAPTKDM4EHPGD
SCHEMBL26315180 0.77 HDAC1 (0.61) ALDH1A1MAPTKDM4EHPGDCYP1A2
SCHEMBL3070077 0.76 PDE4B (0.53) ALDH1A1CYP1A2
SCHEMBL12571352 0.76 CDC7 (0.51) ALDH1A1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3725798-B1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD (CN) 2026-03-04 EP disclosed
EP-4667495-A2 BIOACTIVE MOLECULE CONJUGATE, PREPARATION METHOD AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2025-12-24 EP disclosed
EP-4600271-A2 BIOACTIVE MOLECULE CONJUGATE, PREPARATION METHOD AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2025-08-13 EP disclosed
US-20240382612-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD (CN) 2024-11-21 US disclosed
US-11970506-B2 Bioactive molecule conjugate, preparation method and use thereof SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2024-04-30 US disclosed
US-20230357259-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2023-11-09 US disclosed
US-20230357259-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2023-11-09 US disclosed
US-20230357259-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2023-11-09 US disclosed
CN-113698414-A Bioactive substance conjugate and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-11-26 CN disclosed
CN-113683622-A Bioactive substance conjugate and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-11-23 CN disclosed
CN-113603703-A Bioactive substance conjugate and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-11-05 CN disclosed
CN-111295389-B Bioactive substance conjugate and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-10-22 CN disclosed
US-20210101906-A2 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2021-04-08 US disclosed
US-20210101906-A2 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2021-04-08 US disclosed
US-20200347075-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2020-11-05 US disclosed
US-20200347075-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2020-11-05 US disclosed
EP-3725798-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2020-10-21 EP disclosed
EP-3725798-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2020-10-21 EP disclosed
CN-111295389-A Bioactive substance conjugate and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2020-06-16 CN disclosed
WO-2019114666-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2019-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357259-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF DOCK11, PAICS, RHOA MEN1 886/4885KMT2A 3498/4885ALDH1A1 1175/4885
US-11970506-B2 Bioactive molecule conjugate, preparation method and use thereof PIGO, RHOA, GUSB MEN1 1659/4885KMT2A 3060/4885ALDH1A1 1690/4885
US-20200347075-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF DOCK11, PAICS, RHOA MEN1 886/4885KMT2A 3498/4885ALDH1A1 1175/4885
US-20210101906-A2 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF DOCK11, PAICS, RHOA MEN1 886/4885KMT2A 3498/4885ALDH1A1 1175/4885
US-20240382612-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF DOCK11, PAICS, RHOA MEN1 886/4885KMT2A 3498/4885ALDH1A1 1175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.